WTC
PRCT icon

WhitTier Trust Company’s Procept Biorobotics PRCT Stock Holding History

WhitTier Trust Company’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.4K Buy
101
+87
+621% +$2.45K ﹤0.01% 1254
2025
Q4 		$486 Hold
14
– – ﹤0.01% 1241
2025
Q3 		$504 Hold
14
– – ﹤0.01% 1239
2025
Q2 		$806 Hold
14
– – ﹤0.01% 1371
2025
Q1 		$815 Hold
14
– – ﹤0.01% 1350
2024
Q4 		$1.13K Buy
+14
New +$1.2K ﹤0.01% 1271

Other funds holding PRCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

WhitTier Trust Company's PRCT Position: Q1 2026 in Review

WhitTier Trust Company increased its Procept Biorobotics (PRCT) stake by 621% in Q1 2026, buying an estimated $2.45K and bringing the position to 101 shares worth $2.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1254.

WhitTier Trust Company first reported a position in PRCT in Q4 2024 and has held it in 6 quarters since. 256 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • WhitTier Trust Company held 101 shares of Procept Biorobotics worth $2.4K as of Q1 2026.
  • WhitTier Trust Company bought 87 Procept Biorobotics shares in Q1 2026, an estimated $2.45K.
  • Procept Biorobotics made up ﹤0.01% of WhitTier Trust Company's portfolio in Q1 2026, its #1254 holding.
  • WhitTier Trust Company first reported a position in Procept Biorobotics in Q4 2024 and has held it in 6 quarters since.
  • 256 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on WhitTier Trust Company's 13F filing for Q1 2026, filed 28 Apr 2026.